Skip to content
New platform coming soon — AI-Based Analysis with Human-Generated Insights
Stock Target Advisor Stock Target Advisor Market intelligence
  • Research
  • Market Analysis
  • Analyst Ratings
  • Top Stocks
  • Contact

Stock Target Advisor

Search results for “ABSI”

Market News & Insights Nov 15, 2023

American Analyst Ratings November 15th (ABSI) (ACLX) (AEO) (CRMD) (HD) (HUT) (PD) (VAC) (ZM)

US Stock Ratings ABSI Absci Corp ABSI H.C. Wainwright Reiterated by Buy – Buy 4 ACLX Arcellx Inc ACLX H.C. Wainwright Maintains…

#analyst ratings #energy stocks #Mining Stocks
Analyst Updates: Sept 28th, 2026
Market News & Insights Sep 29, 2026

Analyst Updates: Sept 28th, 2026

Analyst Ratings: Today’s rating updates suggest a selective outlook for U.S. and Canadian stocks. Analysts raised targets for several energy, gold, health…

#Market News & Insights
Analyst Updates: Sept 23rd, 2026
Market News & Insights Sep 23, 2026

Analyst Updates: Sept 23rd, 2026

Analyst Ratings — September 23, 2026 Today’s Canadian and U.S. analyst ratings point to a selective market outlook. Analysts remain bullish on…

#Market News & Insights
American Analyst Updates: June 15th, 2026
Market News & Insights Jun 15, 2026

American Analyst Updates: June 15th, 2026

Analyst Ratings (USA) Today’s analyst ratings show a mixed but still broadly constructive market tone, with increasing dispersion in conviction.  Analysts continue…

#analyst ratings #Artificial Intelligence #Canadian Markets
Market Analysis for March 25th, 2026
Market News & Insights Jul 3, 2025

Analyst Coverage Updates: July 3rd, 2025

Analyst Ratings (USA) 4D Molecular Therapeutics (FDMT) is rated a Buy with a $25.00 target reiterated by Chardan Capital. Absci (ABSI) is…

#analyst ratings #Canadian Markets #energy stocks

Posts pagination

1 2 3 Next
Stock Target Advisor

Timely market news, analyst rating changes, and practical investment research for investors around the world.

  • Research
  • Analyst Ratings
  • Market Analysis
  • Top Stocks
  • About Us
  • Contact Us
  • Contribute a Post
© 2026 Stock Target Advisor. All rights reserved.